Life Saving Drugs Program resources – Paroxysmal nocturnal haemoglobinuria

A collection of resources for health professionals to help people with paroxysmal nocturnal haemoglobinuria access eculizumab (Soliris®) under the Life Saving Drugs Program.

This collection contains guidelines, forms and documents related to accessing eculizumab (Soliris®) under the Life Saving Drugs Program. Click to view the Soliris® product information on the Therapeutic Goods Administration website.

Fact sheets on changes to eculizumab



Medicines review documents

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Last updated:
Publication type:
Health sector

Help us improve

If you would like a response please use the enquiries form instead.